Media error: Format(s) not supported or source(s) not found
Download File: https://www.alembicglobal.com/wp-content/uploads/2015/02/Loop_SKY.webmDownload File: http://www.alembicglobal.com/wp-content/uploads/2015/02/Loop_SKY.mp4Download File: http://www.alembicglobal.com/alembic/wp-content/uploads/2015/02/Loop_SKY.ogv
Alembic Global Advisors is an independent equity research firm offering differentiated, experienced financial analysis on a variety of global industrial sectors. Our goal is to provide high quality, proprietary and actionable research into company, industry and broader macro trends on a truly global level.
Since its founding in 2009, Alembic has expanded from its core global chemical coverage to the aerospace & defense sector. Our analysts have been recognized by industry publications Institutional Investor, FT/Starmine and Extel.2 research analysts covering 35 companies across 3 industries (Chemicals and Aerospace & Defense). Our coverage list continues to grow as we remain focused on delivering our best-in-class research product.
Through our corporate access events we provide unique opportunities to meet with a select group of industry leaders, offering the chance to gain unique insights from people operating at the highest levels of their respective industries.
In addition to highly analytical deep dive research surrounding our specific equity coverage, we provide our macro view of each industry against the global backdrop of current events and how we see them shaping the future. We leverage our various areas of expertise to produce a collaborative cross-sector research product. This non-siloed approach allows us to maximize our areas of expertise, ultimately achieving a more dynamic and in-depth level of insight.
Not a client? Please contact Stephen Matthews – stephen.matthews@alembicglobal.com – to learn more about our research subscription offerings.
Access is limited to Alembic Global Advisors clients.
Key Points We’re updating our forecast for BA after management commentary last week that indicated BA’s commercial supply chain is performing well, putting the firm in position to deliver more ......
Key Points History suggests that demand- and profitability-plagued periods, like 2022-2024, were followed by rapid margin and volume gains Several countries imposing anti-dumping duties on Chinese TiO2 could be the ......
Key Points We’re updating our forecast for HEI post the firm’s 1QFY25 earnings release for the first time. We’re also reiterating our Overweight rating on the shares. We’ve raised our ......
Key Points Share price decline overdone, valuation cheap, and debt levels manageable See company organically being able to pay down debt. If need be, asset sales could also accelerate debt ......
Key Points We’re updating our forecast for AVAV post last week’s 3QFY25 earnings release and reiterating our Overweight rating, though we’re lowering our target price. Our target price declines by ......
Key Points Outperformance of European chemical equities pointing to a positive inflection in fundamentals particularly if a Russia-Ukraine peace deal is brokered Do not see Europe giving up on their ......